Basic Information
| RNALocate ID: | RLID:01001323 |
| RNA Symbol: | hsa-miR-23a-3p |
| Localization: | Mitochondrion |
RNA Information
| RNA Name: | hsa-miR-23a |
| RNA ID: | miRBase:MIMAT0000078 |
| RNA Category: | miRNA |
| Species: | Homo sapiens |
Localization Information
| PubMed ID: | 27396686 |
| Tissue/Cell Line: | Myotube |
| Method: | qRT-PCR |
| Description: | Interestingly, miRNA loaded AGO2 and AGO3 proteins has been recently found in mitochondria [19] (Fig. 2), however, the main AGO binding partner-GW182- was absent [185], indicating that the common cytoplasmic RNA-silencing machinery does not operate in mitochondria. |
Other Subcellular Localization
| RNALocate ID | Localization | Tissue/Cell line | PubMed ID |
| RLID:01001321 | Cytoplasm | Cell line (HeLa) | 21695135 |
| RLID:01001322 | Cytoplasm | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001324 | Mitochondrion | Skeletal muscle myoblasts | 21637849 |
| RLID:01001325 | Mitochondrion | Cell line (HEK-293|HeLa) | 22984580 |
| RLID:01001326 | Nucleus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001327 | Nucleolus | Breast adenocarcinoma cells (MCF-7)|Cervical adenocarcinoma cells (HeLa) | 24918059 |
| RLID:01001328 | Nucleus | Colon adenocarcinoma cells | 20864815 |
| RLID:11000805 | Apoptotic body | Human umbilical vein endothelial cells | 19996457 |
| RLID:11000806 | Exosome | Pooled sera | 27278097 |
| RLID:11000807 | Exosome | LAC cell line (A549) | 27492069 |
| RLID:11000808 | Exosome | Saliva | 19627513 |
| RLID:11000809 | Exosome | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11000810 | Exosome | Breast cancer cell line (MCF-7) | 20976003 |
| RLID:11000811 | Exosome | B cell line (Raji)|Primary dendritic cells|T cell line (J77) | 21505438 |
| RLID:11000812 | Exosome | Renal cancer cells | 21670082 |
| RLID:11000813 | Exosome | Ovarian follicular fluid | 22116803 |
| RLID:11000814 | Exosome | Brain tissue | 23382797 |
| RLID:11000815 | Exosome | Plasma | 23663360 |
| RLID:11000816 | Exosome | Human mast cell line (HMC-1) | 24009880 |
| RLID:11000817 | Exosome | Colon cancer cell line (LIM1863) | 25330373 |
| RLID:11000818 | Extracellular vesicle | HEK-293T cells | 22849433 |
| RLID:11000819 | Microvesicle | Hepatocellular carcinoma cell line (HepG2)|Lung epithelial carcinoma cell line (A549) | 20615901 |
| RLID:11000820 | Microvesicle | Plasma | 23077538 |
| RLID:11000821 | Microvesicle | Seminal plasma | 23539611 |
| RLID-D:11000015 | Exosome | Blood|B lymphoblastoid cells|Breast milk|Chronic lymphocytic leukemia cells|Colon tissue|Endothelial cells|Epithelial cells|Mast cells|Tongue tissue | |
| RLID-D:11000277 | Microvesicle | Blood|Colon cancer cell line (LIM1863)|Fibroblasts|Mesenchymal stem cells|Urine |
ncRNA Disease Information
| Resource | RNA Symbol | Disease | Link |
| MNDR | hsa-miR-23a-3p | Multiple sclerosis chronic progressive | MNDR-E-MI-31866 |
| MNDR | hsa-miR-23a-3p | Colorectal adenoma | MNDR-E-MI-31867 |
| MNDR | hsa-miR-23a-3p | Tongue squamous cell carcinoma | MNDR-E-MI-31868 |
| MNDR | hsa-miR-23a-3p | Oral squamous cell carcinoma | MNDR-E-MI-31869 |
| MNDR | hsa-miR-23a-3p | Large cell neuroendocrine cancer | MNDR-E-MI-31870 |
| MNDR | hsa-miR-23a-3p | Medulloblastoma | MNDR-E-MI-31871 |
| MNDR | hsa-miR-23a-3p | B cell lymphoma of malt type | MNDR-E-MI-31872 |
| MNDR | hsa-miR-23a-3p | High-grade serous ovarian carcinoma | MNDR-E-MI-31873 |
| MNDR | hsa-miR-23a-3p | Lymphoma | MNDR-E-MI-31874 |
| MNDR | hsa-miR-23a-3p | Acute promyelocytic leukemia | MNDR-E-MI-31875 |
| MNDR | hsa-miR-23a-3p | Anencephaly | MNDR-E-MI-31876 |
| MNDR | hsa-miR-23a-3p | Niemann-pick disease type c | MNDR-E-MI-31877 |
| MNDR | hsa-miR-23a-3p | Precursor cell lymphoblastic leukemia-lymphoma | MNDR-E-MI-31878 |
| MNDR | hsa-miR-23a-3p | Prostate cancer | MNDR-E-MI-31879 |
| MNDR | hsa-miR-23a-3p | Gastric cancer | MNDR-E-MI-31880 |
| MNDR | hsa-miR-23a-3p | Leukodystrophy metachromatic | MNDR-E-MI-31881 |
| MNDR | hsa-miR-23a-3p | Alzheimer disease | MNDR-E-MI-31882 |
| MNDR | hsa-miR-23a-3p | Dysautonomia familial | MNDR-E-MI-31883 |
| MNDR | hsa-miR-23a-3p | Myotonic dystrophy | MNDR-E-MI-31884 |
| MNDR | hsa-miR-23a-3p | Head and neck cancer | MNDR-E-MI-31885 |
| MNDR | hsa-miR-23a-3p | Vogt-koyanagi-harada disease | MNDR-E-MI-31886 |
| MNDR | hsa-miR-23a-3p | Leukemia | MNDR-E-MI-31887 |
| MNDR | hsa-miR-23a-3p | Huntington disease | MNDR-E-MI-31888 |
| MNDR | hsa-miR-23a-3p | Chorea | MNDR-E-MI-31889 |
| MNDR | hsa-miR-23a-3p | Cardiovascular disease | MNDR-E-MI-31890 |
| MNDR | hsa-miR-23a-3p | Carotid stenosis | MNDR-E-MI-31891 |
| MNDR | hsa-miR-23a-3p | Moyamoya disease | MNDR-E-MI-31892 |
| MNDR | hsa-miR-23a-3p | Lung cancer | MNDR-E-MI-31893 |
| MNDR | hsa-miR-23a-3p | Down syndrome | MNDR-E-MI-31894 |
| MNDR | hsa-miR-23a-3p | Fragile x syndrome | MNDR-E-MI-31895 |
| MNDR | hsa-miR-23a-3p | Parkinson disease | MNDR-E-MI-31896 |
| MNDR | hsa-miR-23a-3p | Niemann-pick disease | MNDR-E-MI-31897 |
| MNDR | hsa-miR-23a-3p | Colonic adenomas | MNDR-E-MI-31898 |
| MNDR | hsa-miR-23a-3p | Breast cancer | MNDR-E-MI-31899 |
| MNDR | hsa-miR-23a-3p | Pancreatic cancer | MNDR-E-MI-31900 |
| MNDR | hsa-miR-23a-3p | Melanoma | MNDR-E-MI-31901 |
| MNDR | hsa-miR-23a-3p | Lesch-nyhan syndrome | MNDR-E-MI-31902 |
| MNDR | hsa-miR-23a-3p | Nephroblastoma | MNDR-E-MI-31903 |
| MNDR | hsa-miR-23a-3p | Colon cancer | MNDR-E-MI-31904 |
| MNDR | hsa-miR-23a-3p | Multiple sclerosis relapsing-remitting | MNDR-E-MI-31905 |
| MNDR | hsa-miR-23a-3p | Familial ovarian cancer | MNDR-E-MI-31906 |
| MNDR | hsa-miR-23a-3p | Prostate adenocarcinoma | MNDR-E-MI-31907 |
| MNDR | hsa-miR-23a-3p | Carcinoma ductal breast | MNDR-E-MI-31908 |
| MNDR | hsa-miR-23a-3p | Glioblastoma | MNDR-E-MI-31909 |
| MNDR | hsa-miR-23a-3p | Astrocytoma | MNDR-E-MI-31910 |
| MNDR | hsa-miR-23a-3p | Glioma | MNDR-E-MI-31911 |
| MNDR | hsa-miR-23a-3p | Chordoma | MNDR-E-MI-31912 |
| MNDR | hsa-miR-23a-3p | Amyotrophic lateral sclerosis | MNDR-E-MI-31913 |
| MNDR | hsa-miR-23a-3p | Osteosarcoma | MNDR-E-MI-31914 |
| MNDR | hsa-miR-23a-3p | Pancreatic ductal adenocarcinoma | MNDR-E-MI-31915 |
| MNDR | hsa-miR-23a-3p | Meningioma | MNDR-E-MI-31916 |
| MNDR | hsa-miR-23a-3p | Liver cancer | MNDR-E-MI-31917 |
| MNDR | hsa-miR-23a-3p | Uterine cancer | MNDR-E-MI-31918 |
| MNDR | hsa-miR-23a-3p | Cervical adenocarcinoma | MNDR-E-MI-31919 |
| MNDR | hsa-miR-23a-3p | Gastric adenocarcinoma | MNDR-E-MI-31920 |
| MNDR | hsa-miR-23a-3p | Lung squamous cell carcinoma | MNDR-E-MI-31921 |
| MNDR | hsa-miR-23a-3p | Non-small cell lung cancer | MNDR-E-MI-31922 |
| MNDR | hsa-miR-23a-3p | Lung adenocarcinoma | MNDR-E-MI-31923 |
| MNDR | hsa-miR-23a-3p | Thyroid carcinoma | MNDR-E-MI-31924 |
| MNDR | hsa-miR-23a-3p | Ovarian carcinoma | MNDR-E-MI-31925 |
| MNDR | hsa-miR-23a-3p | Pancreatic adenocarcinoma | MNDR-E-MI-31926 |
| MNDR | hsa-miR-23a-3p | Myasthenia gravis autoimmune experimental | MNDR-E-MI-31927 |
| MNDR | hsa-miR-23a-3p | Carcinoma renal cell | MNDR-E-MI-31928 |
| MNDR | hsa-miR-23a-3p | Kidney renal papillary cell carcinoma | MNDR-E-MI-31929 |
| MNDR | hsa-miR-23a-3p | Clear cell renal cell carcinoma | MNDR-E-MI-31930 |
| MNDR | hsa-miR-23a-3p | Intrahepatic cholangiocarcinoma | MNDR-E-MI-31931 |
| MNDR | hsa-miR-23a-3p | Cholangiocarcinoma | MNDR-E-MI-31932 |
| MNDR | hsa-miR-23a-3p | Esophageal cancer | MNDR-E-MI-31933 |
| MNDR | hsa-miR-23a-3p | Lung small cell carcinoma | MNDR-E-MI-31934 |
| MNDR | hsa-miR-23a-3p | Head and neck squamous cell carcinoma | MNDR-E-MI-31935 |
| MNDR | hsa-miR-23a-3p | T acute lymphoblastic leukemia | MNDR-E-MI-31936 |
| MNDR | hsa-miR-23a-3p | Acute t cell leukemia | MNDR-E-MI-31937 |
| MNDR | hsa-miR-23a-3p | Heart failure | MNDR-E-MI-31938 |
| MNDR | hsa-miR-23a-3p | Fibromyalgia | MNDR-E-MI-31939 |
| MNDR | hsa-miR-23a-3p | Adenoma | MNDR-E-MI-31940 |
| MNDR | hsa-miR-23a-3p | Breast invasive carcinoma | MNDR-E-MI-31941 |
| MNDR | hsa-miR-23a-3p | Hepatocellular carcinoma | MNDR-E-MI-31942 |
| MNDR | hsa-miR-23a-3p | Familiar ovarian carcinoma | MNDR-E-MI-31943 |
| MNDR | hsa-miR-23a-3p | B-cell lymphoma | MNDR-E-MI-31944 |
| MNDR | hsa-miR-23a-3p | Rheumatoid arthritis | MNDR-E-MI-31945 |
| MNDR | hsa-miR-23a-3p | Barrett's adenocarcinoma | MNDR-E-MI-31946 |
| MNDR | hsa-miR-23a-3p | Osteoarthritis | MNDR-E-MI-31947 |
| MNDR | hsa-miR-23a-3p | Hodgkin lymphoma | MNDR-E-MI-31948 |
| MNDR | hsa-miR-23a-3p | Ulcerative colitis | MNDR-E-MI-31949 |
| MNDR | hsa-miR-23a-3p | Burkitt lymphoma | MNDR-E-MI-31950 |
| MNDR | hsa-miR-23a-3p | Tonsil cancer | MNDR-E-MI-31951 |
| MNDR | hsa-miR-23a-3p | Acute myelogenous leukemia | MNDR-E-MI-31952 |
| MNDR | hsa-miR-23a-3p | Colorectal cancer | MNDR-E-MI-31953 |
| MNDR | hsa-miR-23a-3p | Nasopharynx carcinoma | MNDR-E-MI-31954 |
| MNDR | hsa-miR-23a-3p | Type 2 diabetes mellitus | MNDR-E-MI-31955 |
| MNDR | hsa-miR-23a-3p | Acute lymphocytic leukemia | MNDR-E-MI-31956 |
| MNDR | hsa-miR-23a-3p | Ependymoma | MNDR-E-MI-31957 |
| MNDR | hsa-miR-23a-3p | Cardiomegaly | MNDR-E-MI-31958 |
| MNDR | hsa-miR-23a-3p | Nasopharyngeal cancer | MNDR-E-MI-31959 |
| MNDR | hsa-miR-23a-3p | Prostatic neoplasms | MNDR-E-MI-31960 |
| MNDR | hsa-miR-23a-3p | Sleep deprivation | MNDR-E-MI-31961 |
| MNDR | hsa-miR-23a-3p | Cerebral hemorrhage traumatic | MNDR-E-MI-31962 |
| MNDR | hsa-miR-23a-3p | Intracranial hemorrhage hypertensive | MNDR-E-MI-31963 |
| MNDR | hsa-miR-23a-3p | Venous thromboembolism | MNDR-E-MI-31964 |
| MNDR | hsa-miR-23a-3p | Stroke lacunar | MNDR-E-MI-31965 |
| MNDR | hsa-miR-23a-3p | Barrett's carcinogenesis | MNDR-E-MI-31966 |
| MNDR | hsa-miR-23a-3p | Tubulovillous adenoma | MNDR-E-MI-31967 |
RNA Interaction Information
| Resource | RNA Symbol | Species | Link | RNALocate ID |
| RNAInter | APAF1 | Homo sapiens | RR00088393 |
TOP